Neovasc Inc.

Recent News

  • Neovasc Receives Administrative Acceptance Review Notification for Premarket Approval Application from FDA for the Neovasc Reducer(TM)

    Vancouver, British Columbia--(Newsfile Corp. - January 15, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") , a leader in the development of minimally invasive transcatheter mitral valve replaceme

    2020-01-15 7:00 AM ET
  • Neovasc Inc. Investor Update

    Vancouver, British Columbia--(Newsfile Corp. - January 13, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve rep

    2020-01-13 7:00 AM ET
  • Neovasc Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - January 6, 2020) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) announced today that it has closed its previously announced registered direct offering (the "Offering") priced at-the-market under Nasdaq rules of an aggregate of 1,185,000 series A units ("Series A Units") ...

    2020-01-06 3:03 PM ET
  • Neovasc Announces $10 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - January 2, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain institutional investors for the sale of an aggregate of 2,418,322 series A units ("Series A Units") and series B units ...

    2020-01-02 8:17 AM ET
  • Neovasc Submits Premarket Approval Application to FDA for Neovasc Reducer(TM)

    Vancouver, British Columbia--(Newsfile Corp. - December 31, 2019) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced the submission ...

    2019-12-31 7:00 AM ET
  • Neovasc Reducer(TM) Featured In National Geographic Magazine

    Vancouver, British Columbia--(Newsfile Corp. - December 17, 2019) -  Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the ...

    2019-12-17 7:00 AM ET
  • Neovasc Named Finalist in Questex's Fierce Innovation Awards Lifesciences Edition 2019

    Vancouver, British Columbia--(Newsfile Corp. - December 4, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has been ...

    2019-12-04 9:58 AM ET
  • Neovasc Reducer(TM) Featured In FOCUS Magazine

    Vancouver, British Columbia and Berlin, Germany--(Newsfile Corp. - November 26, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, ...

    2019-11-26 7:00 AM ET